[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4]=[CH:3][C:2]=1[CH2:11]Br.[OH:13][CH:14]([C:20]1[CH:21]=[C:22]([CH:24]=[CH:25][CH:26]=1)[NH2:23])[CH2:15][CH2:16][CH2:17][CH2:18][CH3:19]>>[OH:13][CH:14]([C:20]1[CH:21]=[C:22]([CH:24]=[CH:25][CH:26]=1)[NH:23][CH2:11][C:2]1[CH:3]=[CH:4][C:5]2[C:10](=[CH:9][CH:8]=[CH:7][CH:6]=2)[N:1]=1)[CH2:15][CH2:16][CH2:17][CH2:18][CH3:19]For compounds in which X is --NR2 --(CHR1)n --, the corresponding amino starting compounds are employed to form the desired amino coppound. Thus, 2-aminopyridine is condensed with 3-(1-hydroxyhexyl)benzyloromide to form 2-[3-(1-hydroxyhexyl)benzylamino]pyridine. Alternatively, 2-quinolylmethylbromide is condensed with 3-(1-hydroxyhexyl)aniline to form 2-[3-(1-hydoxyhexyl) anilinomethyl]quinoline.
불러오는 중…